On April 9, former DOJ Antitrust head Doha Mekki delivered the Lastowka lecture to a packed house of students and faculty.
Author: Michael Carrier
Prof. Carrier testifies to NJ legislature on PBMs
Prof. Carrier testified in front of the New Jersey Assembly Financial Institutions and Insurance Committee on pharmacy benefit managers (PBMs) https://www.assemblydems.com/CivicAlerts.aspx?AID=12554
Prof. Carrier publishes 4 articles
1. (With Ed Bank) – Drug patent agreements and caselaw ambiguity from settlement of antitrust challenges to agreements… https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4909201 2. (With Marc Edelman) – Why NCAA settlement doesn’t preclude future antitrust challenges… https://papers.ssrn.com/sol3/papers.cfm?abstract_id=5053658 3. (With David Katz) – How promises to reasonably license patents have been avoided by “patent pools” and how to address this… … Continue reading Prof. Carrier publishes 4 articles…
Prof. Carrier co-authors “PBMs and Product Hopping” article
Professor Michael Carrier published PBMs and Product Hopping (with Victoria Field) in CPI Antitrust Chronicle. The article explores two reasons for higher drug prices that have previously been examined separately–pharmacy benefit managers (PBMs) and “product hopping” from one drug to another–but have not yet been considered in combination.
Prof. Carrier participated in a Competition Policy International webinar on standards
Professor Michael Carrier participated in a webinar hosted by Competition Policy International on “The Evolving Landscape of Standard-Essential Patents.” He served on the panel: “A Global Perspective.”